Yu-Waye Chu, Chief Medical Officer at FATE THERAPEUTICS INC (FATE), sold 8,124 shares at $35.37 ($287K) on 2022-04-19, disclosed to the SEC on 2022-04-21.
Open-market sale of $287k FATE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.37 | 4,062 | $144K | 50.0% |
| 2 | $35.37 | 4,062 | $144K | 50.0% |
| Total | $35.37 avg | 8,124 | $287K | 100% |
| Filing → |
| FATE | SELL | 2023-04-19 | $17K | — | Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-01-13 | $364K | — | Filing → |